Related Experiment Video
Updated: Nov 25, 2025

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.3K
A road map from single-cell transcriptome to patient classification for the immune response to trauma
Tianmeng Chen1,2, Matthew J Delano3, Kong Chen4
1Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
JCI Insight
|December 15, 2020
Summary
Trauma triggers significant immune cell changes, particularly in monocytes, leading to distinct patient subtypes with varying recovery outcomes. This cellular immune response pattern is shared across critical illnesses.
Area of Science:
- Immunology
- Genomics
- Trauma Research
Background:
- Immune dysfunction significantly impacts trauma outcomes but lacks detailed cellular understanding.
- Understanding the cellular basis of trauma-induced immune responses is crucial for improving patient care.
Purpose of the Study:
- To investigate the cellular and molecular changes in the immune system following trauma.
- To identify distinct immune response patterns in trauma patients and their clinical implications.
Main Methods:
- Single-cell RNA sequencing was performed on mononuclear cells from injured mice and trauma patients.
- Gene expression patterns in monocytes were analyzed to identify key changes and transcription factors.
- Human CD14+ monocyte signatures were defined to classify trauma patient subtypes.
Main Results:
- Trauma induced significant gene expression alterations in monocytes, traceable to myeloid progenitors in mice.
- These monocyte changes were recapitulated in human trauma patients, defining two subtypes (SG1 and SG2).
- SG1 patients showed poorer recovery, increased organ dysfunction, and higher complication rates compared to SG2.
Conclusions:
- Distinct monocyte gene expression signatures define trauma patient subtypes with different clinical trajectories.
- The identified immune response patterns are conserved across critical illnesses like trauma, burns, and sepsis.
- These findings provide a foundation for further research into immune responses in critical illness and inflammatory diseases.

